The natural progression and remission of erectile dysfunction: results from the Massachusetts Male Aging Study
- PMID: 17162054
- DOI: 10.1016/j.juro.2006.08.108
The natural progression and remission of erectile dysfunction: results from the Massachusetts Male Aging Study
Abstract
Purpose: Erectile dysfunction affects more than 150 million men and is strongly associated with cardiovascular disease. A 1992 National Institutes of Health consensus development panel identified erectile dysfunction progression and spontaneous remission as priorities for investigation, but there are few data describing the natural course of the disorder following its initial presentation. This analysis estimates the frequency of erectile dysfunction progression and remission among aging men, and assesses the relation of progression/remission to demographics, socioeconomic factors, comorbidities and modifiable lifestyle characteristics.
Materials and methods: Data from the Massachusetts Male Aging Study, a longitudinal study of men (401) 40 to 70 years old, were analyzed to assess erectile dysfunction severity following initial presentation of symptoms. Logistic regression was used to estimate the odds of erectile dysfunction progression/remission as a function of covariates.
Results: A total of 141 subjects (35%) exhibited erectile dysfunction remission (95% CI: 30%, 40%). Of 323 subjects with minimal or moderate baseline erectile dysfunction 107 (33%) exhibited erectile dysfunction progression (95% CI: 28%, 38%). The 78 subjects with complete erectile dysfunction were considered ineligible for progression and 45 (58%) of these exhibited complete erectile dysfunction at followup. Age and body mass index were associated with progression and remission, while smoking and self-assessed health status were associated with progression only.
Conclusions: Natural remission and progression occur in a substantial number of men with erectile dysfunction. The association of body mass index with remission and progression, and the association of smoking and health status with progression, offer potential avenues for facilitating remission and delaying progression using nonpharmacological intervention. The benefits of such interventions for overall men's health may be far-reaching.
Similar articles
-
Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study.J Urol. 2000 Feb;163(2):460-3. J Urol. 2000. PMID: 10647654
-
Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study.J Urol. 2006 Jul;176(1):222-6. doi: 10.1016/S0022-5347(06)00503-9. J Urol. 2006. PMID: 16753405
-
Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study.Prev Med. 2000 Apr;30(4):328-38. doi: 10.1006/pmed.2000.0643. Prev Med. 2000. PMID: 10731462
-
The health of normally aging men: The Massachusetts Male Aging Study (1987-2004).Exp Gerontol. 2004 Jul;39(7):975-84. doi: 10.1016/j.exger.2004.03.023. Exp Gerontol. 2004. PMID: 15236757 Review. No abstract available.
-
Document for the general public. Spanish consensus panel on erectile dysfunction.Int J Impot Res. 2004 Oct;16 Suppl 2:S7-9. doi: 10.1038/sj.ijir.3901236. Int J Impot Res. 2004. PMID: 15496860 Review. No abstract available.
Cited by
-
[Primary and secondary prevention of erectile dysfunction].Urologe A. 2011 Oct;50(10):1265-8, 1270. doi: 10.1007/s00120-011-2620-9. Urologe A. 2011. PMID: 21877219 Review. German.
-
[Is rehabilitation of erectile function following pelvic surgery reasonable? Review of the literature: from sports to PDE5 inhibitors].Urologe A. 2008 Jun;47(6):685-92. doi: 10.1007/s00120-008-1668-7. Urologe A. 2008. PMID: 18392605 Review. German.
-
A Natural History of Erectile Dysfunction in Elderly Men: A Population-Based, Twelve-Year Prospective Study.J Clin Med. 2022 Apr 12;11(8):2146. doi: 10.3390/jcm11082146. J Clin Med. 2022. PMID: 35456238 Free PMC article.
-
Burden of Urological Complications in Men and Women With Long-standing Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort.Diabetes Care. 2018 Oct;41(10):2170-2177. doi: 10.2337/dc18-0255. Epub 2018 Aug 13. Diabetes Care. 2018. PMID: 30104298 Free PMC article.
-
Erectile tissue molecular alterations with aging: differential activation of the p42/44 MAP Kinase pathway.Age (Dordr). 2011 Jun;33(2):119-30. doi: 10.1007/s11357-010-9167-3. Epub 2010 Jul 14. Age (Dordr). 2011. PMID: 20628826 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical